Skip to main content
Erschienen in: Neurological Sciences 8/2019

23.02.2019 | Letter to the Editor

Is Hirayama a Gq1b disease?

verfasst von: Sezin Alpaydın Baslo, Mücahid Erdoğan, Zeynep Ezgi Balçık, Oya Öztürk, Dilek Ataklı

Erschienen in: Neurological Sciences | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Excerpt

Hirayama disease (HD) or juvenile muscular atrophy of distal upper extremity is a rare benign disease of motor neurons that commonly affects the cervical spinal segments. It is more prevalent in males and mostly seen in teens and early 20s. Slowly progressive unilateral or asymmetrically bilateral weakness of hands and forearms is typical. Sensory disturbances, autonomic and upper motor neuron signs are extremely rare [1]. As the synonym “benign focal amyotrophy” implies, it reaches a plateau after a few years. Electromyography reveals asymmetrical chronic denervation in C7, C8, and T1 myotomes. Preservation of C6 myotomes is remarkable. Supportive MRI findings are anterior shift of posterior dura, enlargement of epidural space, and venous congestion under neck flexion. …
Literatur
1.
Zurück zum Zitat Hirayama K, Toyokura Y, Tsubaki T (1959) Juvenile muscular atrophy of unilateral upper extremity: a new clinical entity. Psychiatr Neurol Jpn 61:2190–2198 Hirayama K, Toyokura Y, Tsubaki T (1959) Juvenile muscular atrophy of unilateral upper extremity: a new clinical entity. Psychiatr Neurol Jpn 61:2190–2198
2.
Zurück zum Zitat Coban A, Ulusoy C, Giris M, Turan S, Turkoglu R, Tuzun E, Idrisoglu HA (2013) Serum anti-neuronal antibodies in amyotrophic lateral sclerosis. Int J Neurosci 123(8):557–562CrossRefPubMed Coban A, Ulusoy C, Giris M, Turan S, Turkoglu R, Tuzun E, Idrisoglu HA (2013) Serum anti-neuronal antibodies in amyotrophic lateral sclerosis. Int J Neurosci 123(8):557–562CrossRefPubMed
3.
Zurück zum Zitat Kollewe K, Wurster U, Sinzenich T, Körner S, Dengler R, Mohannadi V et al (2015) Anti ganglioside antibodies in amyotophic lateral sclerosis revisited. PLoS One 10(4):e0125339CrossRefPubMedPubMedCentral Kollewe K, Wurster U, Sinzenich T, Körner S, Dengler R, Mohannadi V et al (2015) Anti ganglioside antibodies in amyotophic lateral sclerosis revisited. PLoS One 10(4):e0125339CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Liao MF, Chang HS, Chang KH, Ro LS, Chu CC, Kuo HC, Lyu RK (2016) Correlations of clinical, neuroimaging, and electrophysiological features in Hirayama disease. Medicine 95(28):e4210CrossRefPubMedPubMedCentral Liao MF, Chang HS, Chang KH, Ro LS, Chu CC, Kuo HC, Lyu RK (2016) Correlations of clinical, neuroimaging, and electrophysiological features in Hirayama disease. Medicine 95(28):e4210CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Zhou B, Chen L, Fan DS, Zhou D (2010) Clinical features of Hirayama disease in mainland China. Amyotroph Lateral Scler 11:133–139CrossRefPubMed Zhou B, Chen L, Fan DS, Zhou D (2010) Clinical features of Hirayama disease in mainland China. Amyotroph Lateral Scler 11:133–139CrossRefPubMed
6.
Zurück zum Zitat Yoo SD, Kim H-S, Yun DH, Kim DH, Chon J, Lee SA, Lee SY, Han YJ (2015) Monomelic amyotrophy with upper motor neuron signs: a case report. Ann Rehabil Med 39(1):122–127CrossRefPubMedPubMedCentral Yoo SD, Kim H-S, Yun DH, Kim DH, Chon J, Lee SA, Lee SY, Han YJ (2015) Monomelic amyotrophy with upper motor neuron signs: a case report. Ann Rehabil Med 39(1):122–127CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Andreadou E, Christodoulou K, Manta P, Karandreas N, Loukaidis P, Sfagos C, Vassilopoulos D (2009) Familial asymmetric distal upper limb amyotrophy (Hirayama disease): report of a Greek family. Neurologist 15:156–160CrossRefPubMed Andreadou E, Christodoulou K, Manta P, Karandreas N, Loukaidis P, Sfagos C, Vassilopoulos D (2009) Familial asymmetric distal upper limb amyotrophy (Hirayama disease): report of a Greek family. Neurologist 15:156–160CrossRefPubMed
8.
Zurück zum Zitat Hirayama K (2000) Juvenile muscular atrophy of distal upper extremity (Hirayam adisease). Intern Med 39:283–290CrossRefPubMed Hirayama K (2000) Juvenile muscular atrophy of distal upper extremity (Hirayam adisease). Intern Med 39:283–290CrossRefPubMed
10.
Zurück zum Zitat Tashiro K, Kikuchi S, Itoyama Y, Tokumaru Y, Sobue G, Mukai E, Akiguchi I, Nakashima K, Kira JI, Hirayama K (2006) Nation wide survey of juvenile muscular atrophy of distal upper extremity (Hirayama disease) in Japan. Amyotroph Lateral Scler Other Motor Neuron Disord 7:38–45CrossRef Tashiro K, Kikuchi S, Itoyama Y, Tokumaru Y, Sobue G, Mukai E, Akiguchi I, Nakashima K, Kira JI, Hirayama K (2006) Nation wide survey of juvenile muscular atrophy of distal upper extremity (Hirayama disease) in Japan. Amyotroph Lateral Scler Other Motor Neuron Disord 7:38–45CrossRef
11.
Zurück zum Zitat Khadilkar S, Patel B, Bhutada A, Chaudhari C (2015) Do longer necks predispose to Hirayama disease? A comparison with mimicks and controls. J Neurol Sci 359:213–216CrossRefPubMed Khadilkar S, Patel B, Bhutada A, Chaudhari C (2015) Do longer necks predispose to Hirayama disease? A comparison with mimicks and controls. J Neurol Sci 359:213–216CrossRefPubMed
12.
Zurück zum Zitat Anuradha S, Fanai V (2016) Hirayama disease: a rare disease with unusual features. Case Rep Neurol Med 2016:5839761PubMedPubMedCentral Anuradha S, Fanai V (2016) Hirayama disease: a rare disease with unusual features. Case Rep Neurol Med 2016:5839761PubMedPubMedCentral
13.
Zurück zum Zitat Bademkiran F, Oto A, Tabakoglu A, Aydogdu İ, Uludag B (2015) Monomelik amyotrophy (Hirayama disease): clinical findings, EMG characteristics and differential diagnosis. JNS (Turkish) 45:558–565 Bademkiran F, Oto A, Tabakoglu A, Aydogdu İ, Uludag B (2015) Monomelik amyotrophy (Hirayama disease): clinical findings, EMG characteristics and differential diagnosis. JNS (Turkish) 45:558–565
14.
Zurück zum Zitat Jin X, Jiang J, Lu F, Xia X, Wang L, Zheng C (2014) Electrophysiological differences between Hirayama disease, amyotrophic lateral sclerosis and cervical spondylotic amyotrophy. BMC Musculoskelet Disord 15:349CrossRefPubMedPubMedCentral Jin X, Jiang J, Lu F, Xia X, Wang L, Zheng C (2014) Electrophysiological differences between Hirayama disease, amyotrophic lateral sclerosis and cervical spondylotic amyotrophy. BMC Musculoskelet Disord 15:349CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Zheng C, Zhu Y, Yang S, Lu F, Jin X, Jiang J (2016) A study of dynamic F-waves in juvenile spinal muscular atrophy of the distal upper extremity (Hirayama disease). J Neurol Sci 367:298–304CrossRefPubMed Zheng C, Zhu Y, Yang S, Lu F, Jin X, Jiang J (2016) A study of dynamic F-waves in juvenile spinal muscular atrophy of the distal upper extremity (Hirayama disease). J Neurol Sci 367:298–304CrossRefPubMed
16.
Zurück zum Zitat Park JS, Ko JY, Park D (2019) The reversible effect of neck flexion on somatosensory evoked potentials in patients with Hirayama disease: a preliminary study. Neurol Sci 40:181–186CrossRefPubMed Park JS, Ko JY, Park D (2019) The reversible effect of neck flexion on somatosensory evoked potentials in patients with Hirayama disease: a preliminary study. Neurol Sci 40:181–186CrossRefPubMed
17.
Zurück zum Zitat Yuksel M, Kalemci O, Yüksel KZ, Erguden C, Yucesoy K (2009) Hirayama hastalığı ve tanıda manyetik rezonans görüntülemenin önemi. Sinir Sistemi Cerrahi Derg 2:191–195 Yuksel M, Kalemci O, Yüksel KZ, Erguden C, Yucesoy K (2009) Hirayama hastalığı ve tanıda manyetik rezonans görüntülemenin önemi. Sinir Sistemi Cerrahi Derg 2:191–195
18.
19.
Zurück zum Zitat Chen CJ, Hsu HL, Tseng YC, Lyu RK, Chen CM, Huang YC, Wang LJ, Wong YC, See LC (2004) Hirayama flexion myelopathy: neutral-position MR imaging findings— importance of loss of attachment. Radiology 231:39–44CrossRefPubMed Chen CJ, Hsu HL, Tseng YC, Lyu RK, Chen CM, Huang YC, Wang LJ, Wong YC, See LC (2004) Hirayama flexion myelopathy: neutral-position MR imaging findings— importance of loss of attachment. Radiology 231:39–44CrossRefPubMed
20.
Zurück zum Zitat Uncini A, Lugaresi A (1999) Fisher syndrome with tetraparesis and antibody to GQ1b: evidence for motor nerve terminal block. Muscle Nerve 22:640–644CrossRefPubMed Uncini A, Lugaresi A (1999) Fisher syndrome with tetraparesis and antibody to GQ1b: evidence for motor nerve terminal block. Muscle Nerve 22:640–644CrossRefPubMed
21.
Zurück zum Zitat Niebroj-Dobosz I, Jamrozik Z, Janik P et al (1999) Anti-neural antibodies in serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients. Acta Neurol Scand 1999 100:238–243CrossRef Niebroj-Dobosz I, Jamrozik Z, Janik P et al (1999) Anti-neural antibodies in serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients. Acta Neurol Scand 1999 100:238–243CrossRef
22.
Zurück zum Zitat Pestronk A, Adams RN, Clawson L et al (1988) Serum antibodies to GM1 ganglioside in amyorophic lateral sclerosis. Neurology 28:1457–1462CrossRef Pestronk A, Adams RN, Clawson L et al (1988) Serum antibodies to GM1 ganglioside in amyorophic lateral sclerosis. Neurology 28:1457–1462CrossRef
23.
Zurück zum Zitat Rosliakova A, Zakroyshchikova I, Bakulin I, Konovalov R, Kremneva E, Krotenkova M, Suponeva N, Zakharova M (2019) Hirayama disease: analysis of cases in Russia. Neurol Sci 40:105–112CrossRefPubMed Rosliakova A, Zakroyshchikova I, Bakulin I, Konovalov R, Kremneva E, Krotenkova M, Suponeva N, Zakharova M (2019) Hirayama disease: analysis of cases in Russia. Neurol Sci 40:105–112CrossRefPubMed
Metadaten
Titel
Is Hirayama a Gq1b disease?
verfasst von
Sezin Alpaydın Baslo
Mücahid Erdoğan
Zeynep Ezgi Balçık
Oya Öztürk
Dilek Ataklı
Publikationsdatum
23.02.2019
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 8/2019
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-019-03758-x

Weitere Artikel der Ausgabe 8/2019

Neurological Sciences 8/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.